Qualigen therapeutics, inc. announces pricing of $3.46 million public offering

Carlsbad, calif., sept. 05, 2024 (globe newswire) -- qualigen therapeutics, inc. (nasdaq: qlgn) (the “company”) today announced the pricing of a public offering of 14,724,058 shares of common stock, par value $0.001 per share (each a “share,” and collectively, the “shares”) at a public offering price of $0.13 per share and pre-funded warrants to purchase up to 11,972,754 shares at a price of $0.129 per pre-funded warrant with an exercise price of $0.001 per share (the “pre-funded warrants”). the pre-funded warrants are exercisable upon issuance and will remain exercisable until exercised in full. the closing of the offering is expected to occur on or about september 6, 2024, subject to the satisfaction of customary closing conditions.
QLGN Ratings Summary
QLGN Quant Ranking